Skip to main content

Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction

This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

Catalog of Federal Domestic Assistance Number: 93.243
Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Jul 9, 2018

For program issues:
Kim Thierry-English

For grants management and budget issues:
Eileen Bermudez


The Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) program provides funding for organizations, tribes, and tribal organizations to expand or enhance access to medication assisted treatment (MAT) services for individuals with opioid use disorder (OUD).

Required activities include:

  • Provide MAT using at least one of the FDA-approved medications for the maintenance treatment of OUD
  • Check the state, county, or local Prescription Drug Monitoring Program, where available, for each new patient admission in compliance with any relevant state rules or regulations
  • Conduct screening and assessment for co-occurring substance use and mental disorders and the delivery or coordination of any services determined to be necessary for the individual patient to achieve and sustain recovery
  • Establish and implement a plan to mitigate the risk of diversion of methadone or buprenorphine and ensure the appropriate use/dose of medication by patients
  • Develop outreach and engagement strategies to increase participation in, and access to, MAT for diverse populations at risk for OUD
  • Build funding mechanisms and service delivery models with rural and resource-limited counties and municipalities
  • Use telehealth services, or other innovative interventions, to reach, engage, and retain clients in treatment
  • Provide recovery support services, including peer recovery support services, designed to improve access to and retention in MAT and facilitate long-term recovery

Eligibility is limited to the domestic states, political subdivisions within states, and public and private nonprofit organizations in states with the highest rates of primary treatment admissions for heroin and opioids per capita and includes those with the most dramatic increases for heroin and opioids, as identified by SAMHSA.

Tribes/tribal organizations across the United States are also eligible to receive funding.

Geographic coverage
Available in 35 states, the District of Columbia, and for tribes and tribal organizations across the country.
Amount of funding

Award ceiling: $524,670 per year
Project period: Up to 3 years
Estimated number of awards: 125
Estimated total program funding: $65,583,803

At least $5,000,000 is set aside for federally recognized American Indian/Alaska Native (AI/AN) tribes/tribal organizations if application volume from tribes/tribal organizations permits.

Application process

Links to the full announcement and online application process are available through

Tagged as
American Indian or Alaska Native · Prescription drug misuse · Substance use and misuse · Telehealth · Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · Indiana · Iowa · Kentucky · Maine · Maryland · Massachusetts · Michigan · Minnesota · Missouri · Montana · New Hampshire · New Jersey · New York · North Carolina · North Dakota · Ohio · Oregon · Pennsylvania · Rhode Island · Tennessee · Utah · Vermont · Virginia · Washington · West Virginia · Wyoming

For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.